ROS1 genomic rearrangements are rare actionable drivers in microsatellite stable colorectal cancer

c‐Ros oncogene 1, receptor tyrosine kinase (ROS1) genomic rearrangements have been reported previously in rare cases of colorectal cancer (CRC), yet little is known about the frequency, molecular characteristics, and therapeutic vulnerabilities of ROS1‐driven CRC. We analyzed a clinical dataset of 4...

Descripción completa

Detalles Bibliográficos
Autores principales: Akhoundova, Dilara, Hussung, Saskia, Sivakumar, Smruthy, Töpfer, Antonia, Rechsteiner, Markus, Kahraman, Abdullah, Arnold, Fabian, Angst, Florian, Britschgi, Christian, Zoche, Martin, Moch, Holger, Weber, Achim, Sokol, Ethan, Fritsch, Ralph M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Cancer Genetics and Epigenetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804412/
https://www.ncbi.nlm.nih.gov/pubmed/36053834
http://dx.doi.org/10.1002/ijc.34257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804412/
https://www.ncbi.nlm.nih.gov/pubmed/36053834
http://dx.doi.org/10.1002/ijc.34257

Ejemplares similares